MIT Engineers Develop Handheld Device to Collect Viable Cells for Early Cancer Detection
Using microfluidic shear stress, the system detaches living cells from excised tissue to support pathology workflows and downstream diagnostic testing.
Using microfluidic shear stress, the system detaches living cells from excised tissue to support pathology workflows and downstream diagnostic testing.
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
NovoPath has introduced a next-generation LIS that integrates digital pathology workflows, unifying case tracking, image management, and reporting to streamline operations and reduce laboratory handoffs.
Laboratories hold years of patient test results, but much of that data remains fragmented and underused despite its potential value for patient care and reimbursement.
Abbott has launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer screening in average-risk adults, reporting 81.1% sensitivity and 90.4% specificity in a 48,000-patient study.